Skip to content

Clinical evalution of Oma Ilagam (Internal) and Sangamver Thylam (External)for the managaement of Kalanjapadai(Psoriasis) in children

Clinical evalution of oma ilagam (internal) and sangamver thylam (external) for kalanjapadai (psoriasis) in children

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035820
Enrollment
30
Registered
2021-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Oma ilagam (internal) Sangamver thylam (external): Oma ilagam is given with milk twice a day after food Dosage 5-7 years - 1.3gm 8-12 years - 2.6gm Sangamver thylam is applied ex

Sponsors

OPD IPD Ayothidoss Pandithar hospital National institite of siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with two or more of the following symptoms Scaling Erythema With or without itching Candle crease sign positive Dryness of skin Cracks followed by itching Auspitz sign positive Thickness

Exclusion criteria

Exclusion criteria: Psoriatic arthritis Eczema Psoriasis with evidence od any other skin disease Fungal infection Any other systemic disorder Lesion with secondary infection Epilepsy

Design outcomes

Primary

MeasureTime frame
Efiicacy of the trial drug is measured by PASI score and improvement in the clinical condition is assured by reducing the degrees of involvement of the body region from 5 to 1Timepoint: 45 days

Secondary

MeasureTime frame
Reduction in the remission of the disease and improvement in the qualitu of life in children Quality of life will be measured with standard published questionarieTimepoint: Before and after treament assessment in interval of 45 days

Countries

India

Contacts

Public ContactDr A Maruthabharani

National institute of siddha

drsureshherbal@gmail.com9962571137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026